Clinical Evaluation of Ksheerbala Taila Matra Basti, Therapeutic Combination of Vatari Guggulu, Maharasnadi Kwatha and Narayan Taila in the Management of Osteoarthritis Knee - Not Given

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of either sex, aged between 30 and 65 years.
•Patient with primary osteoarthritis Knee joint(s) fulfilling the diagnostic criteria of osteoarthritis recommended by the American College of Rheumatology.
•Pain in the affected Knee joint(s) > 3 months (with radiological changes as per Grade I to III of Kellgren & Lawrence Radiological scale)
•Willing and able to participate in the study for 16 weeks

•Patients with Grade IV Kellgren & Lawrence Radiological scale
•History of any trauma/ fractured joint / surgical/diagnostic intervention with reference to the affected joint(s).
•Gross disability in performing daily normal routine i.e. bedridden patients or confined to a wheelchair.
•Patients with co morbidities such as gouty arthritis, rheumatoid arthritis and psoriatic arthritis.
•Patients having any deformity of knee hip or back altering the gait and posture of the patient.
•Patients with uncontrolled hypertension (160/100 mm of Hg).
•Patients with uncontrolled diabetes mellitus{B.S. (F) 126 mg% and / or B.S. (2 hr. PP) 200 mg% and or HbA1c6.5%
•Patients with evidence of malignancy.
•Patients on prolonged ( 6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
•Patients who have a past history of atrial fibrillation, acute coronary syndrome, myocardial infarction, stroke or severe arrhythmia in the last 6 months.
•Patients with any severe renal or hepatic or any other disorder which may interfere in the study.
•Pregnant / lactating woman.
•Patients who are currently participating in any other clinical trial.
•Any other condition which the Principal Investigator thinks may jeopardize the study.

发起方